FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994012511> ?p ?o ?g. }

• W1994012511 endingPage "93" @default.
• W1994012511 startingPage "89" @default.
• W1994012511 abstract "HistopathologyVolume 26, Issue 1 p. 89-93 What is the value of bcl-2 protein detection for histopathologists? F. PEZZELLA, F. PEZZELLA University Department of Cellular Science, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKSearch for more papers by this authorK. GATTER, K. GATTER University Department of Cellular Science, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKSearch for more papers by this author F. PEZZELLA, F. PEZZELLA University Department of Cellular Science, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKSearch for more papers by this authorK. GATTER, K. GATTER University Department of Cellular Science, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UKSearch for more papers by this author First published: January 1995 https://doi.org/10.1111/j.1365-2559.1995.tb00628.xCitations: 47AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat Reference 1 Fukuhara S, Rowley JD, Variakojis D, Golomb HM. Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res. 1979; 39; 3119–3128. 2 Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM. Cloning of the chromosome breakpoint of neoplastic B cells with the t(14:18) chromosome translocation. Science 1984; 226; 1097–1099. 3 Bakhshi A, Jensen JP, Goldman P et al. Cloning the chromosomal breakpoint of t(14:18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985; 41; 899–906. 4 Cleary ML, Sklar J. Nucleotide sequence of a t(14:18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc. Natl. Acad. Sci. USA 1985; 82; 7439–7443. 5 Cleary ML, Galili N, Sklar J. Detection of a second t(14;18) breakpoint cluster region in human follicular lymphoma. J. Exp. Med. 1986; 164; 315–320. 6 Clearly ML, Smith SD, Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcrip; resulting from the t(14;18) translocation. Cell 1986; 47; 19–28. 7 Tsujimoto Y, Croce CM. Analysis of the structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 1986; 83; 5214–5218. 8 Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM. The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Nature 1985; 229; 1390–1393. 9 Tsujimoto Y, Gorham J. Cossman J, Jaffe E, Croce CM. Characterization of the protein product of bcl-2, the gene involved in human follicular lymphoma. Oncogene 1987; 2; 3–7. 10 Ngan BY, Chen-Levy Z, Weiss LM, Warnke RA, Cleary ML. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14:18) translocation. New Engl. J. Med. 1988; 318; 1638–1644. 11 Vaux DL, Cory S, Adams JM. bcl-2 gene promotes haemopoietic cell surival and co-operates with c-myc to immortalise pre-B cells. Nature 1988; 335; 440–442. 12 Hockenberry D, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ. bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348; 334–336. 13 Korsmeyer SJ. bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80; 879–886. 14 Hockenberry DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993; 75; 241–251. 15 McDonnell TJ, Deane N, Platt FM et al. bcl-2 immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57; 79–88. 16 McDonnell TJ, Korsmeyer SJ. Progression from lymphoid hyperplasia to high grade malignant lymphoma in mice transgenic for the t(14;18). Nature 1991; 349; 254–256. 17 Nakayama K, Negishi I, Kuida K et al. Disappearance of the lymphoid system in bcl-2 homozygous mutant chimeric mice. Science 1993; 261; 1584–1588. 18 Veis DJ, Sorensen CM, Shutter JR, Korsmeyer SJ. bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys and hypopigmented hair. Cell 1993; 75; 229–240. 19 Cattoretti G, Pileri S, Parravicini C et al. Antigen unmasking on formalin-fixed, paraffin embedded tissue-sections. J. Pathol. 1993; 171; 83–89. 20 Pezzella F. Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY. Expression of the bcl-2 protein is not specific for the 14:18 chromosomal translocation. Am. J. Pathol. 1990a; 137; 225–232. 21 Hockenberry DM, Zutter M, Hickey W, Nahm M, Korsmeyer S. bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA 1991; 88; 6961–6965. 22 Hanada M, Delia D, Aiello A, Stadmauer E, Reed JC. bcl-2 gene hypometilation and high level expression in B-cell chronic lymphocytic leukaemia. Blood 1993; 82; 1820–1828. 23 Pezzella F, Ralfkiaer E, Gatter K, Mason DY. The incidence of the 14:18 translocation in European cases of follicular lymphoma. Br. J. Haematol. 1990b; 76; 58–64. 24 Gaulard P, D'Agay MF, Peuchmaur M et al. Expression of the bcl-2 gene product in follicular lymphoma. Am. J. Pathol. 1992; 140; 1089–1095. 25 Pezzella F, Jones M, Ralfkiaer E, Ersboll J, Gatter KC, Mason DY. Evaluation of bcl-2 protein expression and 14;18 translocation prognostic markers in follicular lymphoma. Br. J. Cancer 1992; 65; 87–89. 26 Utz GL, Swerdlow SH. Distinction of follicular hyperplasia from follicular lymphoma in B5-fixed tissues: comparison of MT2 and bcl-2 antibodies. Human Pathol. 1993; 24; 1155–1158. 27 Bloomfield CD, Arthur DC, Frizzera G, Levine EG, Peterson BA, Gail-Peczalska KJ. Non-random chromosome abnormalities in lymphoma. Cancer Res. 1983; 43; 2975–2984. 28 Koduru PRK, Filippa DA, Richardson ME et al. Cytogenetic and histologic correlations in malignant lymphoma. Blood 1987; 69; 97–102. 29 Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfleld CD. There are differences in cytogenetic abnormalities among histologic subtypes of the non-Hodgkin's lymphoma. Blood 1985; 66; 1414–1422. 30 Richardson ME, Quanguang C, Filippa DA et al. Intermediate to high grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome change. Blood 1987; 70; 444–447. 31 Aisenberg AC, Wilkes BM, Jacobson JO. The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988; 71; 969–972. 32 Piris MA, Martinez-Montero JC, Orradre JL et al. p53 and bcl-2 expression in high grade B-cell lymphomas. Correlation with survival time. Br. J. Cancer 1993; 69; 337–341. 33 Lorenzen J, Hansmann ML, Pezzella F et al. Expression of bcl-2 oncogene product and chromosomal translocation t(14;18) in Hodgkin's disease. Human Pathol. 1992; 23; 1205–1209. 34 Doussis IA, Pezzella F, Lane DP, Gatter KC, Mason DY. An immunocytochemical study of p53 and bcl-2 protein expression in Hodgkin's disease. Am. J. Clin. Pathol. 1993; 99; 663–667. 35 Bhagat SKM, Medeiros LJ, Weiss LM, Wang J, Raffeld M, Stetler Stevenson M. bcl-2 expression in Hodgkin's disease. Correlation with the t(14;18) translocation and Epstein-Barr virus. Am. J. Clin. Pathol. 1993; 99; 604–608. 36 Delia D, Aiello A, Soligo D et al. bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 1992; 79; 1291–1298. 37 Lu QL, Elia G, Lucas S, Thomas JA. bcl-2 proto-oncogene expression in Epstein-Barr-virus-associated nasopharyngeal carcinoma. Int. J. Cancer 1993; 53; 29–35. 38 Pezzella F, Turley H, Kuzu I et al. bcl-2 protein in non-small-cell lung carcinoma. Immunohistochemical evidence for abnormal expression and correlation with survival. New Engl. J. Med. 1993; 329; 690–694. 39 Colombel M, Symmans F, Gil S et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone refractory human prostate cancer. Am. J. Pathol. 1993; 143; 390–400. 40 McDonnell TJ, Troncoso P, Brisbay SM et al. Expression of the proto-oncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 1992; 52; 6940–6944. 41 Doglioni C, Dei Tos B, Laurino L, Chiarelli C, Barbareschi M, Viale G. The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch. 1994; 424; 47–51. 42 Leek RD, Kaklamanis L, Pezzella F, Gatter KC, Harris AL. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br. J. Cancer 1994; 6; 135–139. 43 Castle VP, Heidelberger KP, Bromemberg J, Ou X, Dole M, Nunez G. Expression of the apoptosis-suppressing protein bcl-2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am. J. Pathol. 1993; 143; 1543–1550. 44 Schwartz LM, Osborne BA. Programmed cell death, apoptosis and killer genes. Immunology Today 1993; 14(12); 582–590. 45 Wyllie AH. Death gets a brake. Nature 1994; 369; 272–273. 46 Raff MC. Cell death genes: Drosophila enters the field. Science 1994; 264; 668–669. 47 Yonish-Rouach F, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature 1991; 32; 345. 48 Pezzella F, Micklem K, Turley H et al. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J. Clin. Pathol. 1994; 47; 592–596. Citing Literature Volume26, Issue1January 1995Pages 89-93 ReferencesRelatedInformation" @default.
• W1994012511 created "2016-06-24" @default.
• W1994012511 creator A5039504469 @default.
• W1994012511 creator A5057939084 @default.
• W1994012511 date "1995-01-01" @default.
• W1994012511 modified "2023-09-26" @default.
• W1994012511 title "What is the value of bcl-2 protein detection for histopathologists?" @default.
• W1994012511 cites W122353466 @default.
• W1994012511 cites W1766242208 @default.
• W1994012511 cites W1970629830 @default.
• W1994012511 cites W1971234510 @default.
• W1994012511 cites W1972311492 @default.
• W1994012511 cites W1994039691 @default.
• W1994012511 cites W1995775226 @default.
• W1994012511 cites W1997208169 @default.
• W1994012511 cites W1999197294 @default.
• W1994012511 cites W2001833692 @default.
• W1994012511 cites W2005061807 @default.
• W1994012511 cites W2009183764 @default.
• W1994012511 cites W2016575124 @default.
• W1994012511 cites W2021724827 @default.
• W1994012511 cites W2024582476 @default.
• W1994012511 cites W2036274324 @default.
• W1994012511 cites W2057257609 @default.
• W1994012511 cites W2061522225 @default.
• W1994012511 cites W2063374921 @default.
• W1994012511 cites W2070184707 @default.
• W1994012511 cites W2072320859 @default.
• W1994012511 cites W2074114480 @default.
• W1994012511 cites W2075576299 @default.
• W1994012511 cites W2075696892 @default.
• W1994012511 cites W2077223361 @default.
• W1994012511 cites W2087042539 @default.
• W1994012511 cites W2089298737 @default.
• W1994012511 cites W2102666057 @default.
• W1994012511 cites W2128313579 @default.
• W1994012511 cites W2159329636 @default.
• W1994012511 cites W2312311567 @default.
• W1994012511 cites W2326930439 @default.
• W1994012511 cites W2330609930 @default.
• W1994012511 cites W2381926878 @default.
• W1994012511 cites W2415779678 @default.
• W1994012511 cites W2461711455 @default.
• W1994012511 cites W4233484287 @default.
• W1994012511 cites W75709240 @default.
• W1994012511 doi "https://doi.org/10.1111/j.1365-2559.1995.tb00628.x" @default.
• W1994012511 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7713489" @default.
• W1994012511 hasPublicationYear "1995" @default.
• W1994012511 type Work @default.
• W1994012511 sameAs 1994012511 @default.
• W1994012511 citedByCount "58" @default.
• W1994012511 countsByYear W19940125112021 @default.
• W1994012511 countsByYear W19940125112022 @default.
• W1994012511 crossrefType "journal-article" @default.
• W1994012511 hasAuthorship W1994012511A5039504469 @default.
• W1994012511 hasAuthorship W1994012511A5057939084 @default.
• W1994012511 hasConcept C119857082 @default.
• W1994012511 hasConcept C2776291640 @default.
• W1994012511 hasConcept C41008148 @default.
• W1994012511 hasConceptScore W1994012511C119857082 @default.
• W1994012511 hasConceptScore W1994012511C2776291640 @default.
• W1994012511 hasConceptScore W1994012511C41008148 @default.
• W1994012511 hasIssue "1" @default.
• W1994012511 hasLocation W19940125111 @default.
• W1994012511 hasLocation W19940125112 @default.
• W1994012511 hasOpenAccess W1994012511 @default.
• W1994012511 hasPrimaryLocation W19940125111 @default.
• W1994012511 hasRelatedWork W1596801655 @default.
• W1994012511 hasRelatedWork W2130043461 @default.
• W1994012511 hasRelatedWork W2350741829 @default.
• W1994012511 hasRelatedWork W2358668433 @default.
• W1994012511 hasRelatedWork W2376932109 @default.
• W1994012511 hasRelatedWork W2382290278 @default.
• W1994012511 hasRelatedWork W2390279801 @default.
• W1994012511 hasRelatedWork W2748952813 @default.
• W1994012511 hasRelatedWork W2899084033 @default.
• W1994012511 hasRelatedWork W2530322880 @default.
• W1994012511 hasVolume "26" @default.
• W1994012511 isParatext "false" @default.
• W1994012511 isRetracted "false" @default.
• W1994012511 magId "1994012511" @default.
• W1994012511 workType "article" @default.